Aseptuva

Bern, Switzerland

seed$2.9M raisedFreshly fundedMedtechDigital HealthPhotonics & Optics

◆ Total Raised

$2.9M

◆ Stage

seed

◆ Location

Bern, Switzerland

◆ Founded

2021

◆ Team size

1-10

◆ Links

◆ About Aseptuva

Swiss-UK medtech startup developing targeted Far-UVC disinfection technology to prevent hospital-acquired infections linked to intravenous catheters.

◆ What sets it apart

Uses guided Far-UVC technology in a catheter adaptor to deliver automated, hands-free disinfection at the point where infections originate.

◆ Sectors

MedtechDigital HealthPhotonics & Optics

◆ Business

Modelhardware

CustomerHospitals and healthcare providers

◆ Notable

◆ Funding rounds

seed$2.9M

18 Sept 2026

Led by Simon Michel, Roger Nitsch, Armin Diethelm, Auxinam, weInvest

With Valuemaker, Fortyone

◆ Explore the market

◆ FAQ

What does Aseptuva do?

Swiss-UK medtech startup developing targeted Far-UVC disinfection technology to prevent hospital-acquired infections linked to intravenous catheters.

Where is Aseptuva based?

Aseptuva is based in Bern, Switzerland, founded in 2021.

How much has Aseptuva raised?

Aseptuva has raised $2.9M in tracked funding and is currently at the seed stage.

Who has invested in Aseptuva?

Investors in Aseptuva include Simon Michel, Roger Nitsch, Armin Diethelm, Auxinam and weInvest.